why choose us

First received: August 01, 2023

Clinical Trial: A Study of SGN-EGFRd2 in Advanced Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Colorectal Neoplasms

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Study of SGN-EGFRd2 in Advanced Solid Tumors

Brief Summary: This study will test the safety of a drug called SGN-EGFRd2 in participants with advanced solid tumors.It will also study the side effects of this drug.A side effect is anything a drug does to the body besides treating the disease.Participants will have cancer that cannot be removed (unresectable) or has spread through the body (metastatic).This study will have three parts.Parts A and B of the study will find out how much SGN-EGFRd2 should be given to participants.Part C will use the dose found in parts A and B to…

Read more